Myers Robert Paul bought MIRM
October 9, 2026 · Form 4 insider transaction
Myers Robert Paul bought 25,000 shares of Mirum Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
25,000
Price
$0.00
Total value
N/A
InsiderMyers Robert Paul
RoleOfficer
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateOctober 9, 2026
Filing dateOctober 14, 2026
Shares owned after25,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.; 1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of September 21, 2026 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date.